Nutex Health (NASDAQ:NUTX) Stock Price Up 6.9% – What’s Next?

Nutex Health Inc. (NASDAQ:NUTX) shares shot up 6.9% on Monday. The stock traded as high as $215.32 and last traded at $224.0050. 20,562 shares were traded during trading, a decline of 88% from the average session volume of 166,768 shares. The stock had previously closed at $209.59.

Analysts Set New Price Targets

A number of research firms have recently issued reports on NUTX. Wall Street Zen upgraded shares of Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, October 3rd. B. Riley Financial reaffirmed a “buy” rating on shares of Nutex Health in a research report on Friday, September 4th. LADENBURG THALM/SH SH began coverage on shares of Nutex Health in a research report on Monday. They issued a “buy” rating and a $336.00 target price for the company. Lake Street Capital reiterated a “buy” rating and issued a $310.00 price target (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Finally, Zacks Research cut shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $323.67.

Nutex Health Stock Down 0.4%

The business’s 50 day simple moving average is $202.12 and its 200 day simple moving average is $150.34. The stock has a market cap of $1.43 billion, a price-to-earnings ratio of 8.18 and a beta of 0.55.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping the consensus estimate of $4.95 by $4.43. The firm had revenue of $210.75 million for the quarter, compared to analyst estimates of $215.03 million. Equities research analysts forecast that Nutex Health Inc. will post 27.58 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Nutex Health news, Director Scott Saunders sold 203 shares of the business’s stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the transaction, the director owned 400 shares of the company’s stock, valued at $85,700. The trade was a 33.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 44.68% of the stock is currently owned by company insiders.

Institutional Trading of Nutex Health

A number of hedge funds have recently made changes to their positions in the business. BlackRock Inc. acquired a new position in shares of Nutex Health during the 2nd quarter worth approximately $69,612,000. Winmill & CO. Inc. acquired a new stake in Nutex Health during the 2nd quarter valued at $11,168,000. Empowered Funds LLC acquired a new stake in Nutex Health during the 2nd quarter valued at $7,720,000. SG Americas Securities LLC boosted its position in Nutex Health by 3,232.6% during the first quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock worth $2,885,000 after purchasing an additional 29,449 shares during the period. Finally, Bank of New York Mellon Corp bought a new position in Nutex Health during the second quarter worth $3,956,000. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.